1 / 7

Glioma diagnosis treatment market 2020

A glioma is a type of tumor that originates in the brain and is also known as a primary brain tumor.

aditi3019
Download Presentation

Glioma diagnosis treatment market 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Glioma Diagnosis Treatment Market 2020-2023 Industry Survey, Growth, Competitive Landscapeand Forecasts to 2023 PREPARED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Glioma Diagnosis Treatment Market 2020-2023 Glioma Diagnosis Treatment Market Highlights Click to add text Brain tumors are one of the prominent causes of cancer among children and teenagers. Glioma is the most common type of brain tumor which accounts for approximately half of all the astrocytoma. The increasing occurrence of glioblastoma over the years is responsible for the growth of the glioma diagnosis and treatment market. The upcoming drug launches and developments in research are instrumental for the growth of the market. In addition, the current unmet need is expected to drive the gliomas industry over the forecast period. Changing financial demands and access to healthcare facilities are some of the factors that are constraining the market growth. Click to add text www.marketresearchfuture.com

  3. Glioma Diagnosis Treatment Market 2020-2023 Glioma Diagnosis Treatmenty Market Regional Analysis • Geographically, the Americas glioma diagnosis and treatment market is segmented into two major regions, namely, North America and South America. • North America accounted for the largest share of the global gliomas industry in 2016, and the trend is expected to continue over the projected period. Moreover, it is anticipated that about 80,000 new cases will be registered related to brain tumors in the year 2017 which includes 26,000 primary malignant brain tumors. • The Americas glioma diagnosis and treatment market is segmented on the basis of type, diagnosis, treatment, grade, location, and end-user. Browse Complete Report with TOC @ https://www.marketresearchfuture.com/reports/glioma-diagnosis-treatment-market-5877 www.marketresearchfuture.com

  4. Glioma Diagnosis Treatment Market 2020-2023 Glioma Diagnosis Treatment Market Segmental Analysis • On the basis of type, the global glioma diagnosis and treatment market is segmented into primary tumors and secondary tumors. The primary tumors are divided into ependymomas, astrocytomas, oligodendrogliomas, brainstem glioma, optic nerve glioma, mixed gliomas, and others. • The ependymomas segment is divided into subependymomas (grade i), myxopapillary ependymomas (grade i), ependymomas (grade ii), and anaplastic ependymomas (grade iii). The astrocytomas segment is divided into anaplastic astrocytomas, glioblastoma multiforme, and benign astrocytomas. The optic nerve glioma segment is divided into malignant optic nerve glioma and benign optic nerve glioma. The mixed gliomas are divided into oligoastrocytomas and others. • On the basis of diagnosis, the global glioma diagnosis and treatment market is classified into neurological exam, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) scan, biopsy, molecular testing, Electroencephalography (EEG), and others. www.marketresearchfuture.com

  5. Glioma Diagnosis Treatment Market 2020-2023 Glioma Diagnosis Treatment MarketKey Players • Thermo Fisher Scientific Inc. (U.S.),  • Emcure Pharmaceuticals Ltd. (India),  • Sigma-Aldrich Co. (U.S.),  • Pfizer Inc. (U.S.), • Taj Pharmaceuticals Limited (India),  • Novartis International AG (Switzerland),  • Teva Pharmaceutical Industries Ltd. (Israel), • GE Healthcare (U.S.),  • Siemens Healthineers (U.S.), • Philips Healthcare (U.S.) Avail Free Sample @ https://www.marketresearchfuture.com/sample_request/5877 www.marketresearchfuture.com

  6. ABOUT US MARKET RESEARCH FUTURE At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  7. MARKET RESEARCH FUTURE THANK YOU sales@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related